ethyl 3-amino-2-methyl-3-oxopropanoate | 42710-28-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ethyl 3-amino-2-methyl-3-oxopropanoate
• 英文别名: 2-methyl-malonamic acid ethyl ester；2-Methyl-malonamidsaeure-aethylester；2-Carbamoylpropanoic acid ethyl ester
• CAS: 42710-28-1
• 化学式: C₆H₁₁NO₃
• mdl: MFCD19204222
• 分子量: 145.158
• InChiKey: KZTLCGTYMXOOFO-UHFFFAOYSA-N

物化性质

• 熔点：
  77 °C
• 沸点：
  268.4±23.0 °C(Predicted)
• 密度：
  1.097±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  69.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 3-amino-2-methyl-3-oxopropanoate 在 silver trifluoromethanesulfonate 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 反应 3.5h， 生成 ethyl 3,3-dicyano-2-(4-(3-methoxy-2,2-dimethyl-3-oxopropyl)oxazol-2-yl)-2-methylpropanoate
  参考文献：
  名称：

  SOLUBLE GUANYLATE CYCLASE STIMULATORS

  摘要：

  该发明提供了Formula (I)的化合物或其药用盐，其中X、Y、Z、R1、R2、R4、Ra以及下标m、p和q如本文所述。这些化合物或其药用盐可以调节人体对环鸟苷酸单磷酸（“cGMP”）的产生，并通常适用于治疗和预防与扰乱的cGMP平衡相关的疾病。该发明还提供了包含Formula (I)的化合物或其药用盐的药物组合物。该发明还涉及使用这些化合物或其药用盐在治疗和预防上述疾病以及为此目的制备药物的方法。

  公开号：

  US20170174693A1
• 作为产物：
  描述：

  2-氰基丙酸甲酯 在 盐酸 作用下， 以 甲酸 为溶剂， 生成 ethyl 3-amino-2-methyl-3-oxopropanoate
  参考文献：
  名称：

  Managing Highly Coordinative Substrates in Asymmetric Catalysis: A Catalytic Asymmetric Amination with a Lanthanum-Based Ternary Catalyst

  摘要：

  Full details of a catalytic asymmetric amination with a lanthanum/amide-based ligand catalyst system are described. A catalyst comprising La(NO3)(3)center dot 6H(2)O, (R)-3a and H-D-Val-V'Bu was identified to promote the catalytic asymmetric amination of nonprotected succinimide derivative 1 with as little as 1 mol % catalyst loading Mechanistic studies by various spectroscopic analyses and several control and kinetic experiments suggested that the catalyst components were in equilibrium between the associated and dissociated forms, and that the reaction likely proceeded through a La(NO3)(3)center dot 6H(2)O/(R)-3a/H-D-Val-O'Bu ternary complex. This catalyst system was also effective for asymmetric amination of N-nonsubstituted alpha-alkoxycarbonyl amides 7, hitherto unprecedented substrates in asymmetric catalysis, probably due to their attenuated reactivity and difficult stereocontrol, affording the amination products in up to > 99% yield and > 99% ee. The high catalytic performance and enantiocontrol of the reaction with highly coordinative substrates were achieved by the activation/recognition of the substrates exerted by coordination to lanthanum and hydrogen bonding cooperatively in the transition state.

  DOI：

  10.1021/ja9052653

文献信息

• [EN] NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF<br/>[FR] NOUVEAUX COMPOSÉS MODULATEURS DU MÉTABOLISME CELLULAIRE ET LEURS UTILISATIONS
  申请人：CRESCENTA BIOSCIENCES

  公开号：WO2021150645A1

  公开（公告）日：2021-07-29

  A class of compounds that bind to fatty acid binding protein (FABP4) and modulate adipocyte metabolism to drive enhanced glucose utilization, as well as pharmaceutical compositions comprising the class of compounds, in combination with a pharmaceutically acceptable diluent or carrier, and optionally, further in combination with a therapeutically active agent, and the use of these compounds in medicine and for the preparation of a medicament in the treatment of disorders acting on the FABP4.

  一类化合物，能够结合到脂肪酸结合蛋白（FABP4）并调节脂肪细胞代谢以促进增强葡萄糖利用，以及包含该类化合物的药物组合物，与药用辅料或载体相结合，并可选地进一步与治疗活性剂相结合，以及这些化合物在医学上的应用和用于制备治疗作用于FABP4的疾病的药物。
• Site isolated base and acid catalyzed azaspirocyclization cascades
  作者：Adam W. Pilling、Jutta Böhmer、Darren J. Dixon

  DOI：10.1039/b716568d

  日期：——

  A one-pot, site isolated base (PS-BEMP) and acid (Si-TsOH) catalyzed cyclization cascade to azaspirocyclic molecules is reported; the reaction is simple to perform, atom efficient (water is the only byproduct) and broad in its scope to a diverse range of azaspirocyclic products.

  报告了一种单锅、位点隔离碱（PS-BEMP）和酸（Si-TsOH）催化的氮杂环分子级联环化反应；该反应操作简单、原子效率高（水是唯一的副产物），而且范围广泛，可生成多种氮杂环产物。
• Soluble guanylate cyclase stimulators
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US10030027B2

  公开（公告）日：2018-07-24

  The invention provides compounds of the Formula (I) or a pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1, R2, R4, Ra, and the subscripts m, p, and q are as described herein. The compounds or their pharmaceutically acceptable salts can modulate the body's production of cyclic guanosine monophosphate (“cGMP”), and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention also provides pharmaceutical compositions which comprise compounds of Formula (I) or pharmaceutically acceptable salts thereof. The invention also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose.

  本发明提供了式（I）化合物 或其药学上可接受的盐，其中 X、Y、Z、R1、R2、R4、Ra 和下标 m、p 和 q 如本文所述。这些化合物或其药学上可接受的盐类可以调节人体产生的环磷酸鸟苷（"cGMP"），通常适用于治疗和预防与 cGMP 平衡紊乱有关的疾病。本发明还提供了包含式（I）化合物或其药学上可接受的盐的药物组合物。本发明还涉及将这些化合物或其药学上可接受的盐用于治疗和预防上述疾病的方法，以及为此目的制备药物的方法。
• Marguery, Bulletin de la Societe Chimique de France, 1905, vol. <3> 33, p. 550
  作者：Marguery

  DOI：——

  日期：——
• Synthesis and tautomerism of 1-substituted 3,3-dialkyl-3,4-dihydroisoquinolines
  作者：B. B. Aleksandrov、M. S. Gavrilov、M. I. Vakhrin、V. S. Shklyaev

  DOI：10.1007/bf00515067

  日期：1985.6